Peter Demuth serves as Executive at Elicio Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Peter Demuth has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Dec 9, 2025 involved exercising options for 362 shares valued at $1.6K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Dec 9, 2025 | ELTX | $1.6K | Option Exercise | 362 | $4.41 | Discretionary |
Peter Demuth currently holds 743 shares of Elicio Therapeutics, Inc. (ELTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Peter Demuth has been a net neutral trader of ELTX stock. They have purchased $0 and sold $0 worth of shares.
Peter Demuth's most recent insider trade was on Dec 9, 2025, when they sold 362 shares at $4.41 per share.
Get notified when new Form 4 filings are submitted